Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
17,553,121
-
Total 13F shares
-
11,745,584
-
Share change
-
+967,340
-
Total reported value
-
$242,331,391
-
Put/Call ratio
-
145%
-
Price per share
-
$20.63
-
Number of holders
-
110
-
Value change
-
-$44,650,421
-
Number of buys
-
69
-
Number of sells
-
48
Institutional Holders of Corbus Pharmaceuticals Holdings, Inc. - Common Stock, par value $0.0001 per share (CRBP) as of Q3 2024
As of 30 Sep 2024,
Corbus Pharmaceuticals Holdings, Inc. - Common Stock, par value $0.0001 per share (CRBP) was held by
110 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
11,745,584 shares.
The largest 10 holders included
Cormorant Asset Management, LP, Octagon Capital Advisors LP, ORBIMED ADVISORS LLC, BlackRock, Inc., VANGUARD GROUP INC, TANG CAPITAL MANAGEMENT LLC, STATE STREET CORP, ADAGE CAPITAL PARTNERS GP, L.L.C., PRICE T ROWE ASSOCIATES INC /MD/, and Ikarian Capital, LLC.
This page lists
106
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.